EVIDENCE FOR A VONWILLEBRAND-FACTOR DEFECT IN FACTOR-VIII BINDING IN 3 MEMBERS OF A FAMILY PREVIOUSLY MISDIAGNOSED MILD HEMOPHILIA-A AND HEMOPHILIA-A CARRIERS - CONSEQUENCES FOR THERAPY AND GENETIC-COUNSELING

被引:73
作者
MAZURIER, C
GAUCHER, C
JORIEUX, S
PARQUETGERNEZ, A
GOUDEMAND, M
机构
[1] Laboratoire de Recherche Sur L'hémostase, Centre Régional de Transfusion Sanguine, Lille
关键词
D O I
10.1111/j.1365-2141.1990.tb06371.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A plasma von Willebrand factor (vWf) defect limited to its failure to bind factor VIII (FVIII) was previously characterized in a woman with FVIII deficiency and normal primary haemostasis. By using in vitro tests we found a similar pattern in three siblings of another family previously thought to be affected with mild haemophilia A. Furthermore, a decrease in vWf ability to bind FVIII was found in the parents and the brother of the three patients. This decrease was consistent with heterozygous expression of a recessive vWf gene abnormality. FVIII deficiency was corrected by infusion with a vWf concentrate almost devoid of FVIII coagulant activity. FVIII recovery and half‐life thus obtained showed that this treatment was more effective than a FVIII infusion performed by way of comparison. These results indicate that this vWf defect may account for FVIII deficiency in patients without the usual laboratory and clinical features of von Willebrand's disease. Changes in therapy and genetic counselling following the new diagnosis in this family emphasize the need to search for such a vWf defect in patients in whom FVIII deficiency is not obviously X‐linked. Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:372 / 379
页数:8
相关论文
共 29 条
[1]  
BERKOWITZ SD, 1989, COAGULATION BLEEDING, P215
[2]   PURIFIED HUMAN FACTOR-VIII PROCOAGULANT PROTEIN - COMPARATIVE HEMOSTATIC RESPONSE AFTER INFUSIONS INTO HEMOPHILIC AND VONWILLEBRAND DISEASE DOGS [J].
BRINKHOUS, KM ;
SANDBERG, H ;
GARRIS, JB ;
MATTSSON, C ;
PALM, M ;
GRIGGS, T ;
READ, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (24) :8752-8756
[3]  
CORNU P, 1961, NOUV REV FR HEMATOL, V1, P231
[4]   CHARACTERIZATION OF THE HUMAN FACTOR-VIII PROCOAGULANT PROTEIN WITH A HETEROLOGOUS PRECIPITATING ANTIBODY [J].
FULCHER, CA ;
ZIMMERMAN, TS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (05) :1648-1652
[5]   IMMUNORADIOMETRIC ASSAY OF FACTOR-VIII - COAGULANT ANTIGEN USING 4 HUMAN-ANTIBODIES - STUDY OF 27 CASES OF HEMOPHILIA-A [J].
GIRMA, JP ;
LAVERGNE, JM ;
MEYER, D ;
LARRIEU, MJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1981, 47 (02) :269-282
[6]   LIMITED PROTEOLYSIS OF HUMAN VONWILLEBRAND-FACTOR BY STAPHYLOCOCCUS-AUREUS V-8 PROTEASE - ISOLATION AND PARTIAL CHARACTERIZATION OF A PLATELET-BINDING DOMAIN [J].
GIRMA, JP ;
CHOPEK, MW ;
TITANI, K ;
DVIE, EW .
BIOCHEMISTRY, 1986, 25 (11) :3156-3163
[7]   LYONIZATION IN HEMOPHILIA - CAUSE OF ERROR IN DIRECT DETECTION OF HETEROZYGOUS CARRIERS [J].
GRAHAM, JB ;
BARROW, ES ;
ELSTON, RC .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1975, 240 (JAN20) :141-146
[8]  
HOWARD MA, 1971, THROMB DIATH HAEMOST, V26, P362
[9]   EVIDENCE THAT NH2-TERMINAL BUT NOT COOH-TERMINAL MOIETY OF PLASMA VON WILLEBRAND FACTOR BINDS TO FACTOR-VIII [J].
JORIEUX, S ;
MAGALLON, T ;
MAZURIER, C .
THROMBOSIS RESEARCH, 1987, 48 (02) :205-210
[10]  
JORIEUX S, 1985, P BARI INT C FACTOR, P14